Anne Samuel
Stock Analyst at JP Morgan
(2.51)
# 2,352
Out of 5,090 analysts
67
Total ratings
54.55%
Success rate
0.07%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $3.94 | +77.66% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $94.51 | +33.32% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $242.00 | +19.83% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $24.02 | +4.08% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $45.93 | +30.63% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $225.85 | -21.63% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $40.50 | -11.10% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $20.29 | +38.00% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $22.41 | -6.29% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $2.60 | +400.00% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $34.35 | -21.40% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.46 | +103.25% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $3.94
Upside: +77.66%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $94.51
Upside: +33.32%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $242.00
Upside: +19.83%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $24.02
Upside: +4.08%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $45.93
Upside: +30.63%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $225.85
Upside: -21.63%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $40.50
Upside: -11.10%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $20.29
Upside: +38.00%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $22.41
Upside: -6.29%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $2.60
Upside: +400.00%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $34.35
Upside: -21.40%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.46
Upside: +103.25%